Home > Products > Primary Cells > Animal Primary Cells > Mouse Primary cells >
C57BL/6 Mouse Peritoneal Macrophages-Thioglycollate-elicited | ||||
|---|---|---|---|---|
| Product Name | C57BL/6 Mouse Peritoneal Macrophages-Thioglycollate-elicited | |||
| Price | Get Quote | |||
| Cat.No | ABC-TC3227 | Species | C57BL/6 Mouse | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | Mouse peritoneal macrophages (MPMAC) are derived from the thioglycollate-elicited peritoneal cavity of pathogen-free laboratory adult mice. MPMAC are negative for bacteria, yeast, fungi, and mycoplasma. | |||
| Disease | Normal | |||
| Source Organ | Peritoneal | |||
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. | |||
| Recommended Medium And Supplement | ABM-TM3227 C57BL/6 Mouse Peritoneal Macrophages-Thioglycollate-elicited Medium Kit | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | For research use only | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Cell Type | Macrophage | |||
| Growth Mode | Adherent | |||
| Product Type | Mouse Primary Cells | |||
| Product Image |  | |||
- ONLINE INQUIRY
- PRODUCT REVIEWS
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of C57BL/6 Mouse Peritoneal Macrophages-Thioglycollate-elicited
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.
